[Clinical studies with fluprednylide acetate].
D000287:Administration, Topical; D000893:Anti-Inflammatory Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000378:metabolism; D003872:Dermatitis / Q000188:drug therapy*; D003877:Dermatitis, Contact / Q000188:drug therapy; D003881:Dermatomycoses / Q000188:drug therapy; D004485:Eczema / Q000188:drug therapy; D005260:Female; D005477:Fluprednisolone / Q000008:administration & dosage* / Q000009:adverse effects / Q000378:metabolism; D006801:Humans; D008297:Male; D009450:Neurodermatitis / Q000188:drug therapy; D009779:Occlusive Dressings; D011239:Prednisolone; D012874:Skin Diseases, Infectious / Q000188:drug therapy; D014316:Tritium
D000893:Anti-Inflammatory Agents; D014316:Tritium; D005477:Fluprednisolone; D011239:Prednisolone
Klinische Untersuchungen mit Fluprednylidenazetat.